STAT+: Pharmalittle: Gates commits $120 million to speed generic versions of Merck Covid-19 pill; sales of Biogen Alzheimer’s drug bomb
The Gates Foundation is committing up to $120 million to accelerate production of generic versions of an experimental Merck Covid-19 pill for dozens of low-income countries.
by Ed Silverman
Oct 20, 2021
1 minute
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only
You’re reading a preview, subscribe to read more.
Start your free 30 days